US Stock MarketDetailed Quotes
PTCT PTC Therapeutics
- 28.570
- +3.080+12.08%
Close Apr 26 16:00 ET
- 28.650
- +0.080+0.28%
Post 18:44 ET
2.19BMarket Cap-3715P/E (TTM)
29.270High25.670Low1.65MVolume27.000Open25.490Pre Close46.76MTurnover2.91%Turnover RatioLossP/E (Static)76.70MShares59.84052wk High-2.45P/B1.62BFloat Cap17.53052wk Low--Dividend TTM56.57MShs Float78.720Historical High--Div YieldTTM14.12%Amplitude4.030Historical Low28.410Avg Price1Lot Size
PTC Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 339.94%70.76M | 55.58%-158.42M | 39.57%-100.29M | 61.84%-14.52M | 74.44%-14.12M | 69.72%-29.49M | -41.91%-356.65M | -141.09%-165.96M | 25.68%-38.05M | -77.37%-55.24M |
| Net income from continuing operations | 34.10%-91.58M | -12.09%-626.6M | 8.83%-155.79M | -21.64%-132.97M | -30.77%-198.88M | -9.65%-138.96M | -6.70%-559.02M | -19.28%-170.89M | 18.19%-109.32M | -28.48%-152.09M |
| Operating gains losses | 108.08%813K | 28.07%38.72M | 183.72%34.41M | -52.05%16.73M | -106.90%-2.36M | -554.25%-10.06M | -36.21%30.23M | -391.24%-41.1M | 101.69%34.89M | 493.05%34.23M |
| Depreciation and amortization | 29.35%55.4M | 83.64%236.59M | 107.65%80.71M | 79.99%62.06M | 74.79%51.01M | 62.75%42.83M | 100.89%128.84M | 106.61%38.87M | 105.83%34.48M | 94.72%29.18M |
| Deferred tax | 75.00%-1K | -36.92%-46.93M | 111.61%3.98M | ---2K | ---50.9M | ---4K | -9,191.78%-34.28M | ---34.28M | --0 | --0 |
| Other non cash items | 134.37%26.82M | -56,374.19%-104.67M | 967.11%5.17M | -1,440.78%-28.28M | -3,269.78%-93.01M | 698.67%11.45M | -99.70%186K | -158.09%-596K | -92.23%2.11M | -116.06%-2.76M |
| Change In working capital | 69.21%65.51M | 95.31%-4M | -291.76%-82.61M | 120.31%7.51M | 227.43%32.39M | 204.12%38.72M | -258.73%-85.34M | -260.52%-21.09M | -293.40%-36.96M | -68.69%9.89M |
| -Change in receivables | 9.04%-39.5M | 96.82%-1.54M | 135.23%8.35M | 70.33%8.14M | 2,258.37%25.4M | -53.06%-43.43M | -7.73%-48.47M | -44.78%-23.7M | 124.87%4.78M | -107.55%-1.18M |
| -Change in inventory | 102.60%120K | -22.72%-8.18M | 200.64%5.94M | -444.15%-4.33M | -1,504.64%-5.18M | -1,417.71%-4.61M | -470.44%-6.67M | -772.78%-5.9M | -239.47%-795K | -466.67%-323K |
| -Change in prepaid assets | 80.10%105.1M | 27.07%-39.77M | -584.60%-103.83M | 87.55%-6.82M | 236.96%12.53M | 137.13%58.35M | -250.88%-54.53M | 34.79%-15.17M | -617.31%-54.82M | -2,301.84%-9.15M |
| -Change in payables and accrued expense | -116.08%-5.39M | 75.54%48.35M | -69.54%7.91M | -24.76%8M | -105.03%-1.09M | 209.27%33.52M | -39.68%27.54M | -29.36%25.97M | -41.32%10.63M | 10.68%21.62M |
| -Change in other current liabilities | 250.05%5.98M | 49.39%-2.31M | 84.90%-551K | -60.14%1.3M | 186.55%933K | -29.10%-3.99M | 32.01%-4.56M | -54.40%-3.65M | 359.27%3.26M | 7.63%-1.08M |
| -Change in other working capital | 29.55%-801K | -140.71%-550K | ---423K | --1.22M | ---214K | ---1.14M | 133.69%1.35M | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 339.94%70.76M | 55.58%-158.42M | 39.57%-100.29M | 61.84%-14.52M | 74.44%-14.12M | 69.72%-29.49M | -41.91%-356.65M | -141.09%-165.96M | 25.68%-38.05M | -77.37%-55.24M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -296.71%-114.93M | -160.91%-176.74M | -391.06%-94.42M | -121.69%-29.6M | -132.87%-23.75M | -159.07%-28.97M | 32.39%290.18M | -52.49%32.44M | 110.88%136.45M | 28.89%72.25M |
| Net PPE purchase and sale | 6.64%-9.59M | 11.18%-28.44M | 35.44%-5.57M | -18.12%-6.36M | 28.22%-6.25M | -10.29%-10.27M | -13.48%-32.02M | 1.19%-8.62M | 7.91%-5.38M | -9.10%-8.7M |
| Net intangibles purchase and sale | -63.98%-54.76M | 23.47%-92.18M | -24.60%-22.9M | -10.69%-22.85M | -40.33%-13.04M | 53.70%-33.4M | -110.87%-120.44M | -20.00%-18.38M | -3.38%-20.64M | -21.53%-9.29M |
| Net investment purchase and sale | -444.18%-50.58M | -112.68%-56.12M | -210.97%-65.96M | -100.24%-390K | -104.95%-4.47M | -88.74%14.7M | 45.36%442.64M | -35.61%59.44M | 79.49%162.47M | 25.91%90.25M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -296.71%-114.93M | -160.91%-176.74M | -391.06%-94.42M | -121.69%-29.6M | -132.87%-23.75M | -159.07%-28.97M | 32.39%290.18M | -52.49%32.44M | 110.88%136.45M | 28.89%72.25M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -86.81%540K | 284.87%646.4M | 104.84%620.49M | 102.40%3.36M | 378.11%18.46M | 250.51%4.09M | 704.48%167.95M | 6,857.23%302.92M | -4,804.13%-140M | -3.86%3.86M |
| Net issuance payments of debt | -8.05%-1.49M | -302.64%-301.38M | -200.00%-300M | --0 | --0 | -8.07%-1.38M | 6,787.23%148.72M | --300M | ---150M | --0 |
| Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | --50M | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -64.10%2.03M | 42.27%29.99M | -49.33%2.42M | -65.56%3.45M | 378.50%18.48M | 131.38%5.66M | -8.74%21.08M | 9.60%4.77M | 236.19%10.01M | -3.86%3.86M |
| Net other financing activities | ---- | 1,869.94%917.79M | --918.07M | ---85K | ---15K | ---182K | ---51.85M | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -86.81%540K | 284.87%646.4M | 104.84%620.49M | 102.40%3.36M | 378.11%18.46M | 250.51%4.09M | 704.48%167.95M | 6,857.23%302.92M | -4,804.13%-140M | -3.86%3.86M |
| Net cash flow | ||||||||||
| Beginning cash position | 106.23%610.28M | 50.05%295.93M | 50.53%181.41M | 28.84%224.5M | 54.01%233.59M | 50.05%295.93M | -8.83%197.22M | -38.93%120.51M | -5.74%174.25M | -1.59%151.68M |
| Current changes in cash | 19.75%-43.63M | 206.71%311.25M | 151.35%425.78M | 2.02%-40.75M | -193.00%-19.41M | -15.20%-54.37M | 1,000.20%101.48M | 4,371.86%169.39M | -352.24%-41.6M | -27.84%20.87M |
| Effect of exchange rate changes | 74.51%-2.03M | 212.34%3.11M | -48.59%3.1M | 80.79%-2.33M | 508.85%10.31M | -581.73%-7.96M | 64.56%-2.77M | 254.84%6.02M | -202.04%-12.14M | -5.20%1.69M |
| End cash Position | 141.71%564.62M | 106.23%610.28M | 106.23%610.28M | 50.53%181.41M | 28.84%224.5M | 54.01%233.59M | 50.05%295.93M | 50.05%295.93M | -38.93%120.51M | -5.74%174.25M |
| Free cash flow | 108.76%6.41M | 45.19%-279.04M | 33.28%-128.75M | 31.75%-43.73M | 54.39%-33.4M | 59.10%-73.16M | -51.22%-509.11M | -107.76%-192.96M | 16.79%-64.07M | -56.60%-73.23M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
